DK1486511T3 - Genfoldning af polypeptider - Google Patents

Genfoldning af polypeptider

Info

Publication number
DK1486511T3
DK1486511T3 DK04006513T DK04006513T DK1486511T3 DK 1486511 T3 DK1486511 T3 DK 1486511T3 DK 04006513 T DK04006513 T DK 04006513T DK 04006513 T DK04006513 T DK 04006513T DK 1486511 T3 DK1486511 T3 DK 1486511T3
Authority
DK
Denmark
Prior art keywords
buffer
polypeptides
repfolding
refolding
alcoholic
Prior art date
Application number
DK04006513T
Other languages
Danish (da)
English (en)
Inventor
Roger Hart
David Reifsnyder
Stuart Builder
Phillip Lester
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK1486511T3 publication Critical patent/DK1486511T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04006513T 1993-08-20 1994-08-15 Genfoldning af polypeptider DK1486511T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/110,664 US5663304A (en) 1993-08-20 1993-08-20 Refolding of misfolded insulin-like growth factor-I
PCT/US1994/009120 WO1995006064A1 (en) 1993-08-20 1994-08-15 Refolding of polypeptides like recombinant insulin-like growth factor igf-i

Publications (1)

Publication Number Publication Date
DK1486511T3 true DK1486511T3 (da) 2007-05-29

Family

ID=22334224

Family Applications (2)

Application Number Title Priority Date Filing Date
DK04006513T DK1486511T3 (da) 1993-08-20 1994-08-15 Genfoldning af polypeptider
DK94927917T DK0714406T3 (da) 1993-08-20 1994-08-15 Genfoldning af polypeptider som rekombinant insulinlignende vækstfaktor IGF-I

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK94927917T DK0714406T3 (da) 1993-08-20 1994-08-15 Genfoldning af polypeptider som rekombinant insulinlignende vækstfaktor IGF-I

Country Status (10)

Country Link
US (3) US5663304A (de)
EP (2) EP1486511B1 (de)
JP (1) JP3648242B2 (de)
AT (2) ATE352568T1 (de)
CA (1) CA2168552C (de)
DE (2) DE69434919T2 (de)
DK (2) DK1486511T3 (de)
ES (2) ES2219649T3 (de)
PT (2) PT714406E (de)
WO (1) WO1995006064A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10504971A (ja) * 1994-09-08 1998-05-19 カイロン コーポレイション インスリン様増殖因子の改善された生産方法
US6756484B1 (en) 1995-04-14 2004-06-29 Cephalon, Inc. IGF-I purification process
US5650496A (en) * 1995-04-14 1997-07-22 Cephalon, Inc. IGF-I purification process
JP2002514890A (ja) * 1995-06-07 2002-05-21 カイロン コーポレイション 酵母宿主から真性のｉｇｆを精製するための方法
US7193042B1 (en) 1995-06-07 2007-03-20 Chiron Corporation Methods for purifying authentic IGF from yeast hosts
US7071313B1 (en) * 1995-06-07 2006-07-04 Cephalon, Inc. Methods of purifying authentic IGF from yeast hosts
SE9504019D0 (sv) * 1995-11-13 1995-11-13 Pharmacia Ab Method for production of proteins
US20020052026A1 (en) * 1997-10-08 2002-05-02 Steven M. Vicik Methods of refolding proteins
US6265542B1 (en) 1997-10-24 2001-07-24 Genentech, Inc. Purification of molecules
US6417330B1 (en) 1998-06-01 2002-07-09 Celtrix Pharmaceuticals, Inc. Insulin-like growth factor binding protein variants
SE9802454D0 (sv) * 1998-07-08 1998-07-08 Pharmacia & Upjohn Ab Production of peptides
ES2297947T3 (es) 1998-09-22 2008-05-01 Genentech, Inc. Ucp4.
US7399751B2 (en) * 1999-11-04 2008-07-15 Sertoli Technologies, Inc. Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
AU774760B2 (en) * 1998-11-30 2004-07-08 Genentech Inc. Ucp5
US7342102B2 (en) 1998-11-30 2008-03-11 Genentech, Inc. Uncoupling protein 5 (UCP5)
AU1891000A (en) * 1999-01-07 2000-07-24 Takeda Chemical Industries Ltd. Process for producing activated protein
US7087411B2 (en) 1999-06-08 2006-08-08 Regeneron Pharmaceuticals, Inc. Fusion protein capable of binding VEGF
DE19930676B4 (de) * 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
AU6347100A (en) * 1999-07-16 2001-02-05 Human Genome Sciences, Inc. Real-time, in situ biomanufacturing process monitoring and control in response to ir spectroscopy
US7118737B2 (en) * 2000-09-08 2006-10-10 Amylin Pharmaceuticals, Inc. Polymer-modified synthetic proteins
EE200300089A (et) * 2000-09-08 2005-02-15 Gryphon Therapeutics, Inc. Sünteetilised erütropoeesi stimuleerivad valgud, nende valmistamismeetodid ning kasutamine
KR20030081315A (ko) * 2000-11-27 2003-10-17 알엠에프 딕타진 에세.아. 화학적으로 합성한 폴리펩티드의 폴딩 방법
US20060252917A1 (en) * 2001-02-08 2006-11-09 University Of Utah Methods for refolding conformationally constrained peptides
CN1553811A (zh) * 2001-09-07 2004-12-08 ӡ�����Ƽ��ɷ����޹�˾ 人组织尿激酶类型纤溶酶原激活物制剂
EP1314739A1 (de) * 2001-11-22 2003-05-28 Bayer Ag Verfahren zur Renaturierung rekombinanter, Disulfid-enthaltender Proteine bei hohen Proteinkonzentrationen in Gegenwart von Aminen
US8143210B2 (en) 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
DE60336754D1 (de) 2002-02-14 2011-05-26 Univ R Enzymbehandlung von nahrungsmitteln für zöliakie-sprue
US20030224476A1 (en) * 2002-03-01 2003-12-04 Szu-Yi Chou Method of producing transglutaminase reactive compound
US7189811B2 (en) * 2002-09-06 2007-03-13 National Institute Of Immunology Process for solubilization of recombinant proteins expressed as inclusion body
EP1563300B1 (de) 2002-11-20 2012-04-18 The Board Of Trustees Of The Leland Stanford Junior University Diagnoseverfahren für sprue/zöliakie
US20050272117A1 (en) * 2003-06-23 2005-12-08 Astrazeneca Ab Method
US20050118145A1 (en) * 2003-07-03 2005-06-02 Jannette Dufour Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
US7579313B2 (en) * 2003-11-18 2009-08-25 The Board Of Trustees Of The Leland Stanford Junior University Transglutaminase inhibitors and methods of use thereof
EP3026109B1 (de) 2005-12-08 2022-03-09 Amgen Inc. Verbesserte herstellung von glykoproteinen unter verwendung von mangan
NZ568809A (en) 2005-12-22 2011-08-26 Genentech Inc Recovering and purification of VEGF proteins from prokaryotic cells using polyanionic agents
JP2009520739A (ja) * 2005-12-23 2009-05-28 アプラゲン ゲーエムベーハー ジスルフィド架橋の形成方法
US20080125580A1 (en) 2006-07-14 2008-05-29 Genentech, Inc. Refolding of Recombinant Proteins
CA2680590C (en) * 2007-03-16 2017-10-17 Jonathan David Gass Combination enzyme therapy for digestion of dietary gluten
US8148105B2 (en) * 2007-03-16 2012-04-03 The Board Of Trustees Of The Leland Stanford Junior University Scaleable manufacturing process for cysteine endoprotease B, isoform 2
KR20190140090A (ko) 2007-07-09 2019-12-18 제넨테크, 인크. 폴리펩티드의 재조합 생산 동안의 디술피드 결합 환원의 방지
US20100203001A1 (en) * 2007-07-11 2010-08-12 Aplagen Gmbh Process for forming disulfide bridges
AU2010228926B2 (en) * 2009-03-26 2015-12-10 Warsaw Orthopedic, Inc. Methods of identifying potential components for targeted drug delivery compositions
EA020621B1 (ru) 2009-06-22 2014-12-30 Амген Инк. Рефолдинг белков с использованием химически контролируемого окислительно-восстановительного состояния
LT3660032T (lt) 2009-06-25 2026-02-25 Amgen Inc. Ne žinduolių sistemoje ekspresuotų baltymų surišamojo gryninimo būdai
US9052323B2 (en) * 2009-08-27 2015-06-09 The University Of Kansas Osmolyte mixture for protein stabilization
WO2011075430A1 (en) * 2009-12-14 2011-06-23 University Of Massachusetts Methods of inhibiting cataracts and presbyopia
WO2012177847A2 (en) * 2011-06-21 2012-12-27 Synthetech Pharmaceuticals, Llc Methods of dissolving blood clots and the like
AU2014236582B2 (en) 2013-03-14 2018-03-29 The University Of Massachusetts Methods of inhibiting cataracts and presbyopia
CR20180294A (es) 2015-11-13 2018-08-10 Univ Massachusetts Moléculas bifuncionales que contienen peg para uso en la inhibición de cataratas y presbicia
WO2022261443A1 (en) * 2021-06-11 2022-12-15 Acutis Diagnostics, Inc. Method for enhanced direct detection of microbial antigens from biological fluids
CN117603332B (zh) * 2023-11-23 2024-09-10 基因科技（上海）股份有限公司 重组人ny-eso-1蛋白的制备方法及其应用

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518256A (en) * 1977-05-23 1985-05-21 Sanders Associates, Inc. Enhanced accuracy optical radar
US4565785A (en) * 1978-06-08 1986-01-21 The President And Fellows Of Harvard College Recombinant DNA molecule
US4673641A (en) * 1982-12-16 1987-06-16 Molecular Genetics Research And Development Limited Partnership Co-aggregate purification of proteins
US4511503A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4620948A (en) * 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4518526A (en) * 1982-12-22 1985-05-21 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4512922A (en) * 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
SE8303626D0 (sv) * 1983-06-23 1983-06-23 Kabigen Ab A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced
WO1985000831A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of insulin-like growth factor
US4710473A (en) * 1983-08-10 1987-12-01 Amgen, Inc. DNA plasmids
DK108685A (da) * 1984-03-19 1985-09-20 Fujisawa Pharmaceutical Co Vaekstfaktor i
US5028531A (en) * 1984-03-19 1991-07-02 Fujisawa Pharmaceutical Company, Ltd. IGF-I fusion proteins; protection of IGF-I from degradation by host cell; and processes for the production thereof
US4738921A (en) * 1984-09-27 1988-04-19 Eli Lilly And Company Derivative of the tryptophan operon for expression of fused gene products
US4572798A (en) * 1984-12-06 1986-02-25 Cetus Corporation Method for promoting disulfide bond formation in recombinant proteins
US4795706A (en) * 1985-01-31 1989-01-03 Eli Lilly And Company Novel expression control sequences
US4652630A (en) * 1985-02-22 1987-03-24 Monsanto Company Method of somatotropin naturation
DE3679343D1 (de) * 1985-03-28 1991-06-27 Chiron Corp Expression durch verwendung von fusionsgenen fuer proteinproduktion.
GB8508340D0 (en) * 1985-03-29 1985-05-09 Creighton T E Production of protein
EP0219814B1 (de) * 1985-10-21 1991-09-11 Fujisawa Pharmaceutical Co., Ltd. Verfahren zur Herstellung von insulinähnlichem Wachstumsfaktor I (IGF-I) und Plasmid zu dessen Herstellung
JPH0759598B2 (ja) * 1986-02-14 1995-06-28 藤沢薬品工業株式会社 ヒトインスリン様成長因子▲ｉ▼の製造法
US4705848A (en) * 1986-06-02 1987-11-10 International Minerals & Chemical Corp. Isolation of bioactive, monomeric growth hormone
DE3783305T2 (de) * 1986-10-09 1993-05-19 Fujisawa Pharmaceutical Co Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i.
JP2502563B2 (ja) * 1987-02-20 1996-05-29 松下電器産業株式会社 フロントパネルの外観仕上げ方法
US5104796A (en) * 1987-04-06 1992-04-14 International Minerals & Chemical Corp. High titer production of human somatomedin c
IL86090A (en) * 1987-04-16 1993-03-15 Cetus Oncology Corp Production of purified, biologically active, bacterially produced recombinant human csf-1
ES2007309T3 (es) * 1987-04-23 1994-11-01 Monsanto Co Secrecion del factor de crecimiento insulinoide 1 en e.coli.
WO1988008849A1 (en) * 1987-05-11 1988-11-17 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
JPS63294796A (ja) * 1987-05-27 1988-12-01 Sagami Chem Res Center タンパク質の再賦活化方法
IL86455A0 (en) * 1987-06-01 1988-11-15 Takeda Chemical Industries Ltd Polypeptide and production thereof
US4985544A (en) * 1987-08-04 1991-01-15 Kyowa Hakko Kogyo Co., Ltd. Process for renaturing fish growth hormone
JPH01132598A (ja) * 1987-10-14 1989-05-25 Pitman Moore Inc 変性剤溶液中に含まれる組換え蛋白質における分子内ジスルフィド結合の生成を促進する方法
CA1340586C (en) * 1988-09-23 1999-06-08 Cetus Corporation Process for recovering microbially produced interferon-beta
US4923967A (en) * 1988-09-26 1990-05-08 Eli Lilly And Company Purification and refolding of recombinant proteins
US5191063A (en) * 1989-05-02 1993-03-02 University Of Medicine And Dentistry Of New Jersey Production of biologically active polypeptides by treatment with an exogenous peptide sequence
GB8915130D0 (en) * 1989-06-30 1989-08-23 Univ Dundee Enzyme production
DE69021462T2 (de) * 1989-07-19 1996-04-18 Tonen Corp Peptidyl prolyl-cis, trans-Isomerase.
US5124444A (en) * 1989-07-24 1992-06-23 Microprobe Corporation Lactam-containing compositions and methods useful for the extraction of nucleic acids
US5158875A (en) * 1989-08-25 1992-10-27 Amgen Inc. Production of biologically active insulin-like growth factor i from high expression host cell systems
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
AU8417091A (en) * 1990-08-20 1992-03-17 Novo Nordisk A/S Biologically active compound, a process for the preparation thereof and use of the same
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
WO1993019084A1 (en) * 1992-03-24 1993-09-30 Synergen, Inc. Refolding and purification of insulin-like growth factor i

Also Published As

Publication number Publication date
CA2168552C (en) 2000-02-15
DE69434919D1 (de) 2007-03-15
JP3648242B2 (ja) 2005-05-18
EP1486511A1 (de) 2004-12-15
PT714406E (pt) 2004-09-30
US5756672A (en) 1998-05-26
CA2168552A1 (en) 1995-03-02
US5808006A (en) 1998-09-15
DK0714406T3 (da) 2004-07-26
EP0714406B1 (de) 2004-04-21
EP1486511B1 (de) 2007-01-24
US5663304A (en) 1997-09-02
ATE264872T1 (de) 2004-05-15
ATE352568T1 (de) 2007-02-15
WO1995006064A1 (en) 1995-03-02
EP0714406A1 (de) 1996-06-05
ES2219649T3 (es) 2004-12-01
DE69433724T2 (de) 2005-04-28
DE69433724D1 (de) 2004-05-27
JPH09501693A (ja) 1997-02-18
DE69434919T2 (de) 2007-11-29
PT1486511E (pt) 2007-04-30
ES2280857T3 (es) 2007-09-16

Similar Documents

Publication Publication Date Title
DK1486511T3 (da) Genfoldning af polypeptider
EP0886648B8 (de) An den erythropoietin-rezeptor bindende zusammensetzungen und peptide
WO2000023472A3 (en) Interferon-beta fusion proteins and uses
CA2168429A1 (en) Expression of fusion polypeptides transported out of cytoplasm without leader sequences
AU3167289A (en) Low toxicity alloy composition for joining and sealing
BG103143A (en) Substituted pyrido- or pirimidocontaining 6,6- or 6,7-bicyclic derivatives
CA2305013A1 (en) Fusion proteins comprising hiv-1 tat and/or nef proteins
DK0816467T3 (da) Silikat-, borat- og nitratfrie frysebeskyttelsesmiddelkoncentrater og kølemiddelsammensætninger omfattende disse
EP1686172A3 (de) Herztransplantate und dafür nützliche Zellzusammensetzungen
DK197186A (da) Fluorescerende mono-, di- eller polyamider af en aminomonocarboxylsyre og en tetrapyrrol indeholdende mindst tre carboxylgrupper
CA2303165A1 (en) Buffers for stabilizing antigens
CA2116066A1 (en) Stabilized composition of troponin for immunoassays and process for stabilizing troponin for immunoassays
CA2157146A1 (en) Heterocyclyl-benzoylguanidines
EP0201151A3 (de) Vorreinigungszusammensetzungen, Aktivatoren dafür und ihre Benutzung beim Löten
EA199900655A1 (ru) Композиция на основе пароксетина
KR910016767A (ko) 신규한 펩티드
AU2511901A (en) Basolateral sorting signal and inhibitors thereof
AU564269B2 (en) Compositions containing s-adenosyl-l methionine
ATE228847T1 (de) Inhibitoren von katalytischen antikörpern
BR9402493A (pt) Composição de micro-emulsão ácida
ATE294189T1 (de) Kristallisation von proteinen
EP1739090A3 (de) Interferon Beta Fusions Proteine und deren Gebrauch
EA200001252A1 (ru) КОМПОЗИЦИЯ РЕКОМБИНАНТНОГО ИНТЕРФЕРОНА-β-1A(IFN-β-1A) ЧЕЛОВЕКА
RU96124294A (ru) Стабилизированная водорастворимая композиция трийодидов 1,2,3- триалкилбензимидазолия
JPH10158282A5 (de)